TONG REN TANG<08069> - Results Announcement (Q3, 2006, Summary)

TONG REN TANG TECHNOLOGIES CO. LTD. announced on 27/10/2006:
(stock code: 08069 )

Year end date                         :31/12/2006
Currency                              :RMB
Auditors' report                      :N/A
3rd Quarterly Report Reviewed by      :Audit Committee

Important Note :

This result announcement form only contains extracted information from
and should be read in conjunction with the detailed results announcement
of the issuer, which can be viewed on the GEM website at

                                          ( Unaudited)      ( Unaudited)
                                              Current Last Corresponding
                                               Period            Period
                                       from 01/01/2006   from 01/01/2005
                                         to 30/09/2006     to 30/09/2005
                                               RMB'000           RMB'000

Turnover                              :        835,579           915,144
Profit/(Loss) from Operations         :        178,818           194,236
Finance cost                          :        (3,419)           (4,460)
Share of Profit/(Loss) of Associates  :            N/A               N/A
Share of Profit/(Loss) of Jointly
         Controlled Entites           :            N/A               N/A
Profit/(Loss) after Taxation & MI     :        150,390           175,460
% Change Over the Last Period         :         -14.29%
          Basic (in dollar)           :      RMB 0.823          RMB 0.96
          Diluted (in dollar)         :            N/A               N/A
Extraordinary (ETD) Gain/(Loss)       :            N/A               N/A
Profit (Loss) after ETD Items         :       150,390           175,460
3rd Quarter Dividends per Share       :            NIL               NIL
(specify if with other options)       :            N/A               N/A
B/C Dates for 3rd Quarter Dividends   :            N/A
Payable Date                          :            N/A
B/C Dates for (-) General Meeting     :            N/A
Other Distribution for Current Period :            NIL
B/C Dates for Other Distribution      :            N/A
                                       (bdi: both days inclusive)

For and on behalf of

Signature :
Name      : CHAN NGAI CHI

Responsibility statement

The directors of the Company (the "Directors") as at the date hereof
hereby collectively and individually accept full responsibility for the
accuracy of the information contained in this results announcement form
(the "Information") and confirm, having made all reasonable inquiries,
that to the best of their knowledge and belief the Information are
accurate and complete in all material respects and not misleading and
that there are no other matters the omission of which would make the
Information herein inaccurate or misleading.The Directors acknowledge
that the Stock Exchange has no responsibility whatsoever with regard to
the Information and undertake to indemnify the Exchange against all
liability incurred and all losses suffered by the Exchange in connection
with or relating to the Information.

1. Basis of presentation
   The Company was incorporated as a joint stock company with
   limited liability in the People's Republic of China (the "PRC")
   on 22 March 2000 and upon the placing of its H shares, was
   listed on the GEM on 31 October 2000. Its ultimate holding
   company is China Beijing Tong Ren Tang Group Co. Ltd.,
   incorporated in Beijing, the PRC.
2. Principal accounting policies
   The accompanying unaudited consolidated results are prepared
   in accordance with the International Financial Reporting
   Standards as published by the International Accounting Standards
   Board. The accounting policies adopted are consistent with those
   followed in the preparation of the Group's annual financial
   statements for the year ended 31 December 2005.
3.  Revenue
                                       For the nine months
                                          ended 30 September
                                         2006        2005
                                       RMB'000      RMB'000
   Sales of medicine:
     Domestic                          806,621      900,875
     Overseas                           28,958       14,269
                                      ---------    ---------
                                       835,579      915,144
                                      =========    =========
4.  Other Gains - Net
                                       For the nine months
                                          ended 30 September
                                         2006        2005
                                       RMB'000      RMB'000
    Interest income                      2,320          953
                                      =========    =========
5. Finance costs
                                       For the nine months
                                          ended 30 September
                                         2006        2005
                                       RMB'000      RMB'000
   Interest expenses                     3,529        3,523
   Exchange gain                          (110)         937
                                      ---------    ---------
                                         3,419        4,460
                                      =========    =========
6. Profit before income tax
   Profit before income tax was determined after charging the following:
                                       For the nine months
                                          ended 30 September
                                         2006        2005
                                       RMB'000      RMB'000
     Depreciation of property,
     plant and equipment                30,281       21,799
                                      =========    =========
7. Income tax expense
   Pursuant to the relevant regulations of the PRC, the applicable
   income tax rate for the Company is 15%.
   With the approval from the Beijing Economic and Technological
   Development Zone Local Tax Bureau(Document
   Jingdishuikaijianmianfa [2000] No. 23), the Company was
   entitled to an exemption from Enterprise Income Tax ("EIT") for
   the first three years from its commencement of operations and a 50%
   reduction for the three years thereafter, on a condition that an
   amount equal to the EIT exemption or reduction from 15% had to be
   appropriated to a non-distributable tax reserve.  The exemption
   and reduction started from 2000 and expired in 2005.
   For the nine months ended 30 September 2006, the applicable
   income tax rate for the Company was 15%, without any tax relief.  For
   the corresponding period in 2005, an amount equal to EIT exempted
   amounting to approximately RMB14,138,000 was transferred to the tax
   The reconciliation of the tax expense of the Group is as
                                       For the nine months
                                          ended 30 September
                                         2006        2005
                                       RMB'000      RMB'000
   Accounting profit                   175,399      189,776
   Tax rate                             15.49%       14.57%
   EIT at tax rate                      27,161       27,656
   Effect of tax benefits of being
    a High-Technology Enterprise             -      (14,138)
                                       ---------    ---------
   Income tax expense                    27,161      13,518
                                       =========    =========
    Except for the Company and Tong Ren Tang Hebei Chinese Medicinal Raw
    Materials Technologies Co., the provision for PRC current income tax
    is based on the statutory rate of 33% of the assessable income of
    each of the companies and enterprises now comprising the Group as
    determined in accordance with the relevant PRC income tax rules and
    regulations for the periods ended 30 September 2006.
    Foreign entities are subject to income tax as required by tax
    laws of countries where those entities operate.
8. Earnings per share
   The calculation of the earnings per share for the nine months
   ended 30 September 2006 was based on the profit attributable to
   equity holders of the Company of approximately
   RMB150,390,000 (2005: RMB175,460,000) divided by the weighted
   average number of shares issued during the period of 182,800,000
   shares (2005: 182,800,000 shares).
   The Company had no potential dilutive shares for the nine months
   ended 30 September 2006 (2005: Nil).